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Introduction: Resectable isolated multiple metastases to the pancreas from renal cell carcinoma are rare. In this
report, we describe a patient with multiple metastases of renal cell carcinoma to the pancreas who was treated
with pylorus-preserving total pancreatectomy.
Case presentation: The patient was a 58-year-old Asian woman who had undergone right nephrectomy for renal cell
carcinoma 20 years earlier. In 2008, she was diagnosed with multiple metastases of renal cell carcinoma to the pancreas
by abdominal computed tomography during routine follow-up for renal cell carcinoma. 18F-2-fluoro-2-deoxyglucose
positron emission tomography/computed tomography showed no accumulation in her body other than the pancreas.
Because of concerns about her quality of life after total pancreatectomy, she underwent pylorus-preserving total
pancreatectomy. After the resection, her control of blood sugar and quality of life were generally satisfactory. She died as
a result of gastrointestinal bleeding 35 months after undergoing pancreatectomy.
Conclusions: Pancreatic metastasectomy should be considered, even for multiple metastases, when the primary tumor is
renal cell carcinoma and the metastatic lesions are isolated.
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Metastatic tumors of the pancreas are rare. Most patients
with metastases to the pancreas are not candidates for
resection, because the lesions are often widespread. It has
been reported that only 1.8 % of patients who undergo
pancreatectomy do so for metastatic cancer [1]. The most
common cancers reported to metastasize to the pancreas
include renal cell carcinoma (RCC), colon cancer, melan-
oma, sarcoma, breast cancer, and lung cancer [2, 3], with
the kidneys being the most common primary tumor site
(70.5 %) [4]. RCCs frequently metastasize only to the pan-
creas, and these metastases may occur a long time after
nephrectomy.
Surgical resection has been reported to improve the
prognosis of patients with RCC [5]. Only 11 % of
metastatic RCCs to the pancreas have been reported
to be multifocal or to have an unsuspected location.* Correspondence: kitadeh@takii.kmu.ac.jp
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gery for these metastases undergo total pancreatec-
tomy (TP) [4]. In this case report, we describe a
patient who underwent pylorus-preserving total pan-
createctomy (PPTP) for multiple metastases to the
pancreas from RCC 20 years after nephrectomy.
Case presentation
A 58-year-old Asian woman was admitted to our hos-
pital for multiple nodular legions in the pancreas. She
had undergone right nephrectomy for RCC 20 years
earlier. Since then, she had undergone soft tissue resec-
tion of the right shoulder (2005), partial left nephrec-
tomy (2006), and partial chest wall resection (2007) for
metastases from RCC, and she was started on interferon
therapy in 2007. In 2008, during routine follow-up,
abdominal computed tomography (CT) revealed mul-
tiple space-occupying legions in the pancreas, but she
had no subjective symptoms. Her carcinoembryonic
antigen and carbohydrate antigen 19-9 levels were
within normal limits. Contrast-enhanced abdominal CT
revealed multiple stained nodules in the pancreas (Fig. 1).e is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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Fig. 1 Contrast-enhanced abdominal computed tomography revealed multiple stained nodules in the pancreas (yellow arrows). a Arterial phase.
b Late phase
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raphy/computed tomography (FDG-PET/CT) showed
FDG accumulation in the tail of the pancreas (standard-
ized uptake value, 2.5) (Fig. 2), but no other accumula-
tions of FDG elsewhere in her body. Abdominal
magnetic resonance imaging (MRI) showed three stained
nodular legions (one each in the head, tail, and body of
the pancreas), but no evidence of dilatation of the main
pancreatic duct or bile duct (Fig. 3). Preoperative differ-
ential diagnoses included pancreatic endocrine tumor
and metastatic carcinoma. On the basis of these findings
and her previous medical history, she was diagnosed
with multiple isolated metastases to the pancreas from
RCC.
As metastases occurred while the patient was being
treated with interferon, surgery was indicated. Intraopera-
tive ultrasonography showed more than four nodules in the
pancreas from the head to the tail, but there was no evi-
dence of lymph node swelling or peritoneal dissemination.
She underwent PPTP with splenectomy. Because all blood
supply to the stomach comes from the left gastric artery via
intramural vessels and all blood drains from the stomach
through the left gastric vein, close attention was paid to
preservation of these vessels. Her pancreas contained ten
macroscopic and more than eleven microscopic metastaticlesions (Figs. 4 and 5). Their pathological diagnosis was
compatible with metastatic clear cell RCC, similar to the
primary RCC resected 20 years earlier (Fig. 5).
Two weeks after PPTP, the patient fell during a
hypoglycemic episode and broke her right femur. Sub-
sequently, however, her control of blood sugar was
generally satisfactory. Adjuvant therapy consisted of
interleukin (IL)-2 (70,000 U/week) for 2 years, after
which IL-2 therapy was discontinued because the
patient was experiencing severe nausea and vomiting.
There was no evidence of RCC recurrence 28 months
after PPTP, but she changed hospitals thereafter. We
were informed by a local hospital that she died as a
result of gastrointestinal bleeding 35 months after
pancreatic resection.
Discussion
Resectable isolated multiple metastases to the pancreas
from RCC are rare. Most of these patients are not candi-
dates for surgical treatment. In this report, we describe a
rare case of isolated multiple metastases to the pancreas
from RCC treated by PPTP.
Diagnosis of metastases to the pancreas from RCC is
often difficult, and thus knowledge of a patient’s medical
history is important when the pancreatic mass is initially
CBA
Fig. 3 Abdominal magnetic resonance imaging scans (a T1 weighted, b T2 weighted MRI image) showing multiple nodular legions in the
pancreas head, tail, and body (yellow arrows). There was no evidence of dilatation of the main pancreatic duct or bile duct (c)
Fig. 2 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography showing 18F-2-fluoro-2-deoxyglucose accumulation in
the tail of the pancreas (standardized uptake value, 2.5)
Kitade et al. Journal of Medical Case Reports  (2015) 9:212 Page 3 of 6
Fig. 4 Macroscopic findings. More than ten macroscopic lesions were observed
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tively easy because she had been followed for a long period
of time after nephrectomy. In general, contrast-enhanced
CT, MRI, and FDG-PET/CT are used for the differential
diagnosis of nodules in the pancreas. Metastases to the pan-
creas from RCC are detected as hypervascular tumors on
contrast-enhanced CT and dynamic MRI and as accumula-
tions of FDG. Small-sized metastatic RCCs, less than
15mm to 20mm in diameter, have been reported to be
homogeneously enhanced [6]. In our patient, small-sized
metastatic RCCs were not detected preoperatively by
contrast-enhanced CT or MRI. FDG-PET/CT is useful for
determining the need for surgery because it can exclude
distant metastases. However, accumulation of FDG is low,
with the number of actual tumors in the resected specimen
generally greater than the number determined by FDG-
PET/CT. For example, FDG-PET in our patient showed
metastatic lesions only in the tail of the pancreas, sug-
gesting that FDG-PET may not be suitable for thedetection of metastatic RCCs in the pancreas. Endo-
scopic ultrasound-guided fine-needle aspiration biopsy
is also used for the definitive diagnosis of metastases
of RCC. This was deemed unnecessary in our patient
because of her history of RCC, the presence of hyper-
vascular tumors on contrast-enhanced CT, and the
local accumulation of FDG, all of which suggested
multiple isolated metastases to the pancreas from
RCC.
The kidney is the most common primary tumor site
(70.5 %) of metastases to the pancreas [4], with many
RCCs metastasizing only to the pancreas and many me-
tastases occurring a long time after nephrectomy. The
pancreatic metastases in our patient occurred 20 years
after initial resection for RCC. Surgical resection has
been reported to improve the prognosis of patients with
RCC [5]. The 5-year overall survival rate after pancrea-
tectomy for RCC metastases has been reported to be 42 %,
much higher than after pancreatectomy for metastases of
Fig. 5 Microscopic findings. The pathological diagnosis was
compatible with metastatic clear cell renal cell carcinoma
(hematoxylin and eosin stain; original magnification, ×100). a Primary
renal cell carcinoma resected 20 years earlier. b Metastatic renal
cell carcinoma
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creas from RCC include interferon, chemotherapy, and
sunitinib, although surgical resection has been found to be
superior.
The surgical procedure to choose depends on the loca-
tion of the metastases. Distal pancreatectomy is the treat-
ment of choice for patients with solitary lesions in the body
or tail of the pancreas, whereas pancreatoduodenectomy is
usually performed in patients with solitary lesions in the
head of the pancreas. In general, TP is performed in pa-
tients with widespread or multiple tumors because it is as
safe as the pylorus-preserving Whipple procedure for the
treatment of benign and malignant neoplasms of the pan-
creas [7]. TP with or without pylorus preservation has been
reported to be safe in patients with metastatic RCC, and
this procedure, along with adequate medical support and
appropriate education after TP, should result in good con-
trol of endocrine and exocrine pancreatic insufficiency as
well as a good quality of life [8]. There are several options
for TP, with or without splenectomy and with or withoutpylorus preservation. PPTP is a standard organ-preserving
procedure for neoplasms of the entire pancreas. We elected
to perform PPTP rather than standard TP plus splenec-
tomy in this patient, for several reasons. First, lymph node
dissection was not necessary, owing to the hematogenous
metastases of RCC [9]. Second, hypoglycemia was found to
be lower after PPTP than after TP [10]. Finally, the inci-
dence of late complications, including uncontrollable dia-
betes, diarrhea, and malnutrition, was reported to be lower
after PPTP than after TP [10]. TP causes loss of endocrine
and exocrine functions. Authors who compared standard
TP with PPTP for pancreatic cancer found no differences
in the rates of early complications, including delayed gastric
emptying and cholangitis [10]. Although the rate of late
complications was higher in patients who underwent stand-
ard TP (9 of 13) than in those who had PPTP (3 of 10), the
difference was not statistically significant. However, serum
albumin level and percentage of preillness body weight 6
months after resection were significantly higher in patients
who underwent PPTP. Several previous case reports have
described the use of PPTP for isolated metastases to the
pancreas from RCC [11, 12].
Another organ-preserving TP procedure for pancreatic
neoplasms is duodenum-preserving total pancreatec-
tomy (DPTP), which was performed on a patient with
multiple metastases of the pancreas from RCC [13].
Preservation of the arterial arcade of the posterior pan-
creas is necessary for the blood supply of the duodenum
and common bile duct, but this procedure is difficult to
perform in some patients. It is also unclear whether
preservation of the duodenum results in good control of
blood sugar and good quality of life. The difficulties in-
volved in performing DPTP, coupled with its as yet
undetermined benefits, suggest that PPTP should be
performed in patients with isolated multiple metastases
to the pancreas from RCC. However, additional studies
comparing these two procedures for this indication are
necessary.
Conclusions
In this case report, we describe the benefits of surgical
resection in a patient with multiple isolated pancreatic
metastases from RCC. Organ-preserving TP is the treat-
ment of choice for these patients, as shown by their bet-
ter quality of life after resection.
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